Urokinase Plasminogen Activator System: A Multifunctional Role in Tumor Progression and Metastasis
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The urokinase plasminogen activator (uPA) system is central to a spectrum of biologic processes including fibrinoloysis, inflammation, atherosclerotic plaque formation, matrix remodeling during wound healing, tumor invasion, angiogenesis, and metastasis. Binding of uPA with its receptor (uPAR) initiates a proteolytic cascade that results in the conversion of plasminogen to plasmin. Plasmin through its own proteolytic function degrades a range of extracellular basement membrane components and activates others such as the metalloproteinases. Independent of catalytic activity, uPAR also is involved in cell signaling, interactions with integrins, cell motility, adhesion and invasion, and angiogenesis. Over expression of uPA or uPAR is a feature of malignancy and is correlated with tumor progression and metastasis. In contrast, inhibition of expression of these components leads to a reduction in the invasive and metastatic capacity of many tumors. Strategies that target uPA or its receptor with the aim of disrupting the interaction between the two or the ligand independent actions of uPAR include antisense technology, monoclonal antibodies, cytotoxic antibiotics, and synthetic inhibitors of uPA. Targeted therapy is a goal of future cancer treatment and the uPA system is a likely candidate for manipulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Angiogenic Factor Cyr61 Activates a Genetic Program for Wound Healing in Human Skin Fibroblasts
Chen, C.-C., Mo, F.-E., & Lau, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107666200 · Cited by 300
Research works printed but not linked: 101
- Aguirre Ghiso, 1999, J Cell Biol, 147, 89, 10.1083/jcb.147.1.89 · DOI · Paper page
- Andreasen, 1990, Mol Cell Endocrinol, 68, 1, 10.1016/0303-7207(90)90164-4 · DOI · Paper page
- Blasi, 1999, Thromb Haemost, 82, 298, 10.1055/s-0037-1615846 · DOI · Paper page
- Bohuslav, 1995, J Exp Med, 181, 1381, 10.1084/jem.181.4.1381 · DOI · Paper page
- Bugge, 1995, J Biol Chem, 270, 16886, 10.1074/jbc.270.28.16886 · DOI · Paper page
- Buo, 1995, Hum Pathol, 26, 1133, 10.1016/0046-8177(95)90276-7 · DOI
- Burgle, 1997, Biol Chem, 378, 231, 10.1515/bchm.1997.378.3-4.231 · DOI · Paper page
- Carmeliet, 1994, Nature, 368, 419, 10.1038/368419a0 · DOI · Paper page
- Chakraborty, 2002, Can J Physiol Pharmacol, 80, 116, 10.1139/y02-016 · DOI · Paper page
- Chandrasekar, 2003, Oncogene, 22, 392, 10.1038/sj.onc.1206164 · DOI
- Chapman, 1997, Curr Opin Cell Biol, 9, 714, 10.1016/S0955-0674(97)80126-3 · DOI · Paper page
- Chavakis, 1998, Blood, 91, 2305, 10.1182/blood.V91.7.2305 · DOI
- Chiaradonna, 1999, EMBO J, 18, 3013, 10.1093/emboj/18.11.3013 · DOI
- Choong, 1996, Int J Cancer, 69, 268, 10.1002/(SICI)1097-0215(19960822)69:4<268::AID-IJC5>3.0.CO;2-V · DOI
- Colman, 1997, J Clin Invest, 100, 1481, 10.1172/JCI119669 · DOI · Paper page
- Conese, 1995, J Cell Biol, 131, 1609, 10.1083/jcb.131.6.1609 · DOI · Paper page
- Crowley, 1993, Proc Natl Acad Sci U S A, 90, 5021, 10.1073/pnas.90.11.5021 · DOI · Paper page
- Cubellis, 1990, EMBO J, 9, 1079, 10.1002/j.1460-2075.1990.tb08213.x · DOI · Paper page
- Dano, 1985, Adv Cancer Res, 44, 139, 10.1016/S0065-230X(08)60028-7 · DOI · Paper page
- Degryse, 1999, Blood, 94, 649, 10.1182/blood.V94.2.649 · DOI · Paper page
- Deng, 1996, J Cell Biol, 134, 1563, 10.1083/jcb.134.6.1563 · DOI · Paper page
- Dewerchin, 1996, J Clin Invest, 97, 870, 10.1172/JCI118489 · DOI · Paper page
- Duffy, 1988, Cancer, 62, 531, 10.1002/1097-0142(19880801)62:3<531::AID-CNCR2820620315>3.0.CO;2-B · DOI · Paper page
- Duffy, 1988, Cancer Res, 48, 1348
- Fisher, 2000, Breast Cancer Res Treat, 61, 1, 10.1023/A:1006445129195 · doi:10.1023/a:1006445129195
- Fisher, 2001, Clin Cancer Res, 7, 1654
- Foekens, 1992, Cancer Res, 52, 6101
- Galimi, 2001, J Immunol, 166, 1241, 10.4049/jimmunol.166.2.1241 · DOI · Paper page
- Gleeson, 1993, Cancer, 72, 1670, 10.1002/1097-0142(19930901)72:5<1670::AID-CNCR2820720529>3.0.CO;2-# · doi:10.1002/1097-0142(19930901)72:5<1670::aid-cncr2820720529>3.0.co;2-#
- Goretzki, 1992, FEBS Lett, 297, 112, 10.1016/0014-5793(92)80339-I · DOI · Paper page
- Grondahl-Hansen, 1993, Cancer Res, 53, 2513
- Guo, 2000, FASEB J, 14, 1400, 10.1096/fasebj.14.10.1400 · doi:10.1096/fasebj.14.10.1400
- Hahn-Dantona, 1999, Ann N Y Acad Sci, 878, 372, 10.1111/j.1749-6632.1999.tb07696.x · DOI
- Hasui, 1996, Urology, 47, 34, 10.1016/S0090-4295(99)80378-1 · DOI
- Heiss, 1995, Nat Med, 1, 1035, 10.1038/nm1095-1035 · DOI · Paper page
- Higazi, 1996, Blood, 87, 3545, 10.1182/blood.V87.9.3545.bloodjournal8793545 · doi:10.1182/blood.v87.9.3545.bloodjournal8793545
- Hildenbrand, 1995, Br J Cancer, 72, 818, 10.1038/bjc.1995.419 · DOI · Paper page
- Hildenbrand, 1995, Pathol Res Pract, 191, 403, 10.1016/S0344-0338(11)80726-0 · doi:10.1016/s0344-0338(11)80726-0
- Hildenbrand, 1999, J Leukoc Biol, 66, 40, 10.1002/jlb.66.1.40 · DOI
- Hofmann, 1996, J Urol, 155, 858, 10.1016/S0022-5347(01)66328-6 · doi:10.1016/s0022-5347(01)66328-6
- Hoyer-Hansen, 1997, FEBS Lett, 420, 79, 10.1016/S0014-5793(97)01491-9 · DOI
- Hsu, 1995, Am J Pathol, 147, 114
- Janicke, 1989, Lancet, 2, 1049, 10.1016/S0140-6736(89)91070-2 · DOI
- Jean, 2001, Crit Rev Immunol, 21, 275, 10.1615/CritRevImmunol.v21.i1-3.180 · DOI
- Jorg, 1985, Thromb Res, 39, 323, 10.1016/0049-3848(85)90228-2 · doi:10.1016/0049-3848(85)90228-2
- Kanse, 1996, Exp Cell Res, 224, 344, 10.1006/excr.1996.0144 · doi:10.1006/excr.1996.0144
- Keyt, 1996, J Biol Chem, 271, 7788, 10.1074/jbc.271.13.7788 · DOI · Paper page
- Kirchheimer, 1989, Eur J Biochem, 181, 103, 10.1111/j.1432-1033.1989.tb14699.x · doi:10.1111/j.1432-1033.1989.tb14699.x
- Kobayashi, 1994, Cancer Res, 54, 6539
- Kobayashi, 1994, Int J Cancer, 57, 727, 10.1002/ijc.2910570520 · DOI · Paper page
- Kobayashi, 1994, Thromb Haemost, 71, 474, 10.1055/s-0038-1642463 · DOI
- Kobayashi, 1991, J Biol Chem, 266, 5147, 10.1016/S0021-9258(19)67767-7 · DOI · Paper page
- Koshelnick, 1997, J Biol Chem, 272, 28563, 10.1074/jbc.272.45.28563 · DOI · Paper page
- Kuhn, 1994, Gynecol Oncol, 55, 401, 10.1006/gyno.1994.1313 · DOI
- Landis, 1998, CA Cancer J Clin, 48, 6, 10.3322/canjclin.48.1.6 · DOI · Paper page
- Lansink, 1998, Blood, 92, 927, 10.1182/blood.V92.3.927 · DOI
- Li, 1998, Gene Ther, 5, 1105, 10.1038/sj.gt.3300742 · DOI · Paper page
- Lijnen, 1994, Eur J Biochem, 224, 567, 10.1111/j.1432-1033.1994.00567.x · doi:10.1111/j.1432-1033.1994.00567.x
- Luparello, 2003, J Cell Sci, 116, 2421, 10.1242/jcs.00472 · DOI
- Mahabeleshwar, 2003, J Biol Chem, 278, 6209, 10.1074/jbc.M208905200 · DOI
- Marchina, 1996, Int J Biochem Cell Biol, 28, 1141, 10.1016/1357-2725(96)00055-6 · doi:10.1016/1357-2725(96)00055-6
- Mignatti, 1996, Enzyme Protein, 49, 117, 10.1159/000468621 · DOI · Paper page
- Miles, 1988, Blood, 72, 628, 10.1182/blood.V72.2.628.628 · DOI
- Mohan, 1999, Cancer Res, 59, 3369
- Mondino, 1999, Thromb Haemost, 82, 19
- Mukhina, 2000, J Biol Chem, 275, 16450, 10.1074/jbc.M909080199 · DOI
- Murphy, 1999, APMIS, 107, 38, 10.1111/j.1699-0463.1999.tb01524.x · DOI · Paper page
- Naldini, 1995, J Biol Chem, 270, 603, 10.1074/jbc.270.2.603 · DOI · Paper page
- Nekarda, 1994, Cancer Res, 54, 2900
- Nguyen, 1999, J Cell Biol, 146, 149, 10.1083/jcb.146.1.149 · DOI · Paper page
- Nguyen, 2000, J Biol Chem, 275, 19382, 10.1074/jbc.M909575199 · DOI · Paper page
- Nielsen, 1988, J Biol Chem, 263, 2358, 10.1016/S0021-9258(18)69214-2 · DOI · Paper page
- Nykjaer, 1997, EMBO J, 16, 2610, 10.1093/emboj/16.10.2610 · DOI · Paper page
- Ohtani, 1995, Int J Cancer, 62, 691, 10.1002/ijc.2910620608 · doi:10.1002/ijc.2910620608
- Park, 1993, Mol Biol Cell, 4, 1317, 10.1091/mbc.4.12.1317 · DOI · Paper page
- Pedersen, 1994, Cancer Res, 54, 4671
- Pedersen, 1994, Cancer Res, 54, 120
- Petersen, 1988, J Biol Chem, 263, 11189, 10.1016/S0021-9258(18)37940-7 · DOI · Paper page
- Ploug, 1991, Semin Thromb Hemost, 17, 183, 10.1055/s-2007-1002608 · DOI
- Ploug, 1991, J Biol Chem, 266, 1926, 10.1016/S0021-9258(18)52382-6 · DOI · Paper page
- Proescholdt, 1999, J Neuropathol Exp Neurol, 58, 613, 10.1097/00005072-199906000-00006 · DOI · Paper page
- Remacle-Bonnet, 1997, Int J Cancer, 72, 835, 10.1002/(SICI)1097-0215(19970904)72:5<835::AID-IJC21>3.0.CO;2-6 · DOI
- Resnati, 1996, EMBO J, 15, 1572, 10.1002/j.1460-2075.1996.tb00502.x · DOI · Paper page
- Rettenberger, 1995, Biol Chem Hoppe Seyler, 376, 587, 10.1515/bchm3.1995.376.10.587 · doi:10.1515/bchm3.1995.376.10.587
- Ribatti, 1999, J Cell Sci, 112, 4213, 10.1242/jcs.112.23.4213 · DOI
- Schmitt, 1991, Biomed Biochim Acta, 50, 731
- Schmitt, 1997, Thromb Haemost, 78, 285, 10.1055/s-0038-1657541 · DOI
- Schmitt, 1997, Br J Cancer, 76, 306, 10.1038/bjc.1997.383 · DOI
- Stack, 1994, J Biol Chem, 269, 9416, 10.1016/S0021-9258(17)36896-5 · DOI · Paper page
- Stahl, 1995, J Cell Biol, 129, 335, 10.1083/jcb.129.2.335 · DOI · Paper page
- Tatsuta, 1997, Int J Oncol, 10, 125
- Van Veldhuizen, 1996, Am J Med Sci, 312, 8, 10.1097/00000441-199607000-00002 · doi:10.1097/00000441-199607000-00002
- Wary, 1998, Cell, 94, 625, 10.1016/S0092-8674(00)81604-9 · DOI · Paper page
- Webb, 2000, Cancer Res, 60, 342
- Webb, 2000, J Cell Sci, 113, 123, 10.1242/jcs.113.1.123 · DOI · Paper page
- Wei, 1994, J Biol Chem, 269, 32380, 10.1016/S0021-9258(18)31646-6 · DOI · Paper page
- Wei, 1999, J Cell Biol, 144, 1285, 10.1083/jcb.144.6.1285 · DOI · Paper page
- Whitesell, 1992, Cancer Res, 52, 1721
- Xu, 1997, Hum Pathol, 28, 206, 10.1016/S0046-8177(97)90108-8 · DOI
- Yebra, 1996, J Biol Chem, 271, 29393, 10.1074/jbc.271.46.29393 · DOI · Paper page
- Zanetti, 1998, J Pathol, 186, 287, 10.1002/(SICI)1096-9896(199811)186:3<287::AID-PATH175>3.0.CO;2-X · doi:10.1002/(sici)1096-9896(199811)186:3<287::aid-path175>3.0.co;2-x
Cited by
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Hicklin, D. J., & Ellis, L. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,007
Kortlever, R. M., Higgins, P. J., & Bernards, R. (2006) · Nature Cell Biology · doi:10.1038/ncb1448 · Cited by 637
Mahmood, N., Mihalcioiu, C., & Rabbani, S. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00024 · Cited by 478
The Molecular Pathogenesis of Osteosarcoma: A Review
Broadhead, M. L., Clark, J. C. M., Myers, D. E., Dass, C. R., & Choong, P. F. M. (2011) · Sarcoma · doi:10.1155/2011/959248 · Cited by 346
Self-citationHuman Tissue Kallikreins: Physiologic Roles and Applications in Cancer
Borgoño, C. A., Michael, I. P., & Diamandis, E. P. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.257.2.5 · Cited by 339
Metadata
- Authors
- Choong, P. F. M., & Nadesapillai, A. P. W.
- Venue
- Clinical Orthopaedics and Related Research
- Published
- 2003-10
- Volume
- 415
- Pages
- S46-S58
- ISSN
- 0009-921X (ISSN-L)
- OpenAlex
- W4231451806
- Cited by
- 145
- References
- 1
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urokinase Plasminogen Activator System: A Multifunctional Role in Tumor Progression and Metastasis. https://app.cochat.ai/papers/10.1097/01.blo0000093845.72468.bd
- The paper
- Choong, P. F. M., & Nadesapillai, A. P. W. (2003). Urokinase Plasminogen Activator System: A Multifunctional Role in Tumor Progression and Metastasis. Clinical Orthopaedics and Related Research. https://doi.org/10.1097/01.blo0000093845.72468.bd
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.